Company intelligence / Profile preview

KCTNS

Ownership: Private
Development stage: Other

Overview

KCAS Bio is an established bioanalytical contract research organization (CRO) with over 40 years of experience. They provide GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and animal health industries. The company has supported more than 300 FDA-approved drugs on the market and developed over 5,000 assays. Their expertise includes global biomarker analysis, immunogenicity testing, cellular/molecular assay services, clinical kitting/sample management, and advanced flow cytometry capabilities.

Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

Salipro Biotech (for membrane protein stabilization technology)Strategic alliance in Australia for global reachParticipation in American Association of Pharmaceutical Scientists (AAPS) working groups on data security

Beyond the preview

Go deeper on KCTNS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KCTNS.

Explore the full profile